Saturday, 31 October 2026European Markets

KEYWARE TECH. And EXCLUSIVE NETWORKS Have A High Dividend Yield And Return On Equity In The Software - Infrastructure Industry.

Loading stream...

(vianews) - keyware tech. (keyw.br) is among this list of stock assets with the highest dividend rate and return on equity on the software - infrastructure industry.

financial asset price forward dividend yield return on equity
keyware tech. (keyw.br) €0.95 10.96% 5.71%
exclusive networks (exn.pa) €16.78 1.03% 4.82%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. keyware tech. (keyw.br)

10.96% forward dividend yield and 5.71% return on equity

keyware technologies nv, an independent fintech company, provides electronic payment solutions in belgium. it offers payment transaction software for banks and financial institutions, tokenization software, instalment payment solutions, and ordering and payment app software; and payment processing and management services, as well as rents and sells payment terminals. the company was incorporated in 1996 and is headquartered in zaventem, belgium.

earnings per share

as for profitability, keyware tech. has a trailing twelve months eps of €0.05.

pe ratio

keyware tech. has a trailing twelve months price to earnings ratio of 19. meaning, the purchaser of the share is investing €19 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.71%.

revenue growth

year-on-year quarterly revenue growth grew by 27.9%, now sitting on 23.97m for the twelve trailing months.

more news about keyware tech..

2. exclusive networks (exn.pa)

1.03% forward dividend yield and 4.82% return on equity

exclusive networks sa operates as a global cybersecurity specialist for digital infrastructure. the company offers endpoint, network, web, and email security related products; and data security, vulnerability and security analytics, and identity access management products. it also provides consulting, outsourcing, deployment and integration, maintenance and support, and managed services. in addition, the company provides security information and event management, content and email security, application, internet of things security, cloud access security broker, and cyber-threats related solutions. further, it offers convergence infrastructure, data storage, data management and data protection, hybrid cloud, and multi-cloud solutions. exclusive networks sa was founded in 1995 and is headquartered in boulogne-billancourt, france.

earnings per share

as for profitability, exclusive networks has a trailing twelve months eps of €0.47.

pe ratio

exclusive networks has a trailing twelve months price to earnings ratio of 35.7. meaning, the purchaser of the share is investing €35.7 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.82%.

volatility

exclusive networks's last week, last month's, and last quarter's current intraday variation average was 0.67%, 0.03%, and 1.10%.

exclusive networks's highest amplitude of average volatility was 1.16% (last week), 1.36% (last month), and 1.10% (last quarter).

yearly top and bottom value

exclusive networks's stock is valued at €16.78 at 21:40 est, way under its 52-week high of €21.15 and way higher than its 52-week low of €15.02.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, exclusive networks's stock is considered to be oversold (<=20).

sales growth

exclusive networks's sales growth is 18.9% for the current quarter and 2.6% for the next.

more news about exclusive networks.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com